Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with a drug company.
Pfizer has agreed to pay $35 million to resolve allegations by 42 states that a subsidiary illegally marketed an organ transplant drug for unapproved uses.
Jackley says the misleading claims put consumers' health at risk.
Authorities say Wyeth Pharmaceuticals, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Rapamune was approved in 1999 for use in kidney transplant patients. It's illegal to promote drugs for uses not cleared by the Food and Drug Administration.
Pfizer says the alleged activity occurred before it acquired Wyeth. The company didn't admit any wrongdoing or liability as part of the settlement.
Most Popular Today
- 1.Meetings & Events
RibFest Announces Concert Headliners
How Much Do You Take Home In Pay?
80 MPH Interstate Speed Limit Starts This Week
Lincoln Continental Makes Its Return For 2015
- 5.Your Money Matters
'Department of Legal Affairs' Phone Scam Targets KELOLAND
- 6.Retail & Restaurants
CH Patisserie To Start Online Shop
- 7.Legislation, Taxes
Senate Overrides Veto Of Electric Cooperative Tax Proposal
Deadwood Moves Forward On $7 Million Visitor Center Project
- 9.Housing, Legislature
Veto Of Plan To Gather Rental Property Data Will Stand
- 10.Your Money Matters, College
School of Mines Rated Best College Value in SD